Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-04-10$6.91/sh−4,862$33,596→ 100,169 total - Award
Common Stock
2025-04-10+19,964→ 105,031 total
Footnotes (1)
- [F1]On February 11, 2022, the reporting person was granted Performance Restricted Stock Units (PSUs) to acquire a total of 57,040 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 19,964 shares.